83 related articles for article (PubMed ID: 20085442)
1. Standardized uptake value is of prognostic value for outcome in head and neck squamous cell carcinoma.
Zhang B; Li X; Lu X
Acta Otolaryngol; 2010 Jul; 130(7):756-62. PubMed ID: 20085442
[TBL] [Abstract][Full Text] [Related]
2. Primary tumor standardized uptake value predicts survival in head and neck squamous cell carcinoma.
Zhang B; Geng J; Nie F; Li X
Oncol Res Treat; 2015; 38(1-2):45-8. PubMed ID: 25633888
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment tumor standardized uptake value as a prognostic factor in primary head and neck squamous cell carcinoma.
Zhang B; Nie F; Jin B; Meng Q; Dong P
Mol Clin Oncol; 2015 Mar; 3(2):392-396. PubMed ID: 25798273
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of [18F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection.
Inokuchi H; Kodaira T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Takada A; Mizoguchi N; Tamaki T; Fuwa N
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):747-55. PubMed ID: 20434274
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
6. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Naitou K; Ueda Y; Ouchi Y
AJR Am J Roentgenol; 2009 Apr; 192(4):W156-60. PubMed ID: 19304675
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis.
Xie P; Li M; Zhao H; Sun X; Fu Z; Yu J
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1085-93. PubMed ID: 21229262
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Wong RJ; Lin DT; Schöder H; Patel SG; Gonen M; Wolden S; Pfister DG; Shah JP; Larson SM; Kraus DH
J Clin Oncol; 2002 Oct; 20(20):4199-208. PubMed ID: 12377963
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project.
Paesmans M; Berghmans T; Dusart M; Garcia C; Hossein-Foucher C; Lafitte JJ; Mascaux C; Meert AP; Roelandts M; Scherpereel A; Terrones Munoz V; Sculier JP;
J Thorac Oncol; 2010 May; 5(5):612-9. PubMed ID: 20234323
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
Machtay M; Natwa M; Andrel J; Hyslop T; Anne PR; Lavarino J; Intenzo CM; Keane W
Head Neck; 2009 Feb; 31(2):195-201. PubMed ID: 19107945
[TBL] [Abstract][Full Text] [Related]
12. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
[TBL] [Abstract][Full Text] [Related]
13. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.
Rasmussen JH; Vogelius IR; Fischer BM; Friborg J; Aznar MC; Persson GF; Håkansson K; Kristensen CA; Bentzen SM; Specht L
Head Neck; 2015 Sep; 37(9):1274-81. PubMed ID: 24801812
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
16. Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
Konski AA; Cheng JD; Goldberg M; Li T; Maurer A; Yu JQ; Haluszka O; Scott W; Meropol NJ; Cohen SJ; Freedman G; Weiner LM
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):358-63. PubMed ID: 17532577
[TBL] [Abstract][Full Text] [Related]
17. High 2-[18F]fluoro-2-deoxy-d-glucose (18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma.
Hofele C; Freier K; Thiele OC; Haberkorn U; Buchmann I
Oral Oncol; 2009 Nov; 45(11):963-7. PubMed ID: 19665923
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.
Vernon MR; Maheshwari M; Schultz CJ; Michel MA; Wong SJ; Campbell BH; Massey BL; Wilson JF; Wang D
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):678-84. PubMed ID: 18262086
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of survival analysis after a 5-year follow-up: Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma.
Mori M; Yabuki K; Taguchi T; Nishimura G; Takahashi M; Komatsu M; Oridate N
Auris Nasus Larynx; 2015 Jun; 42(3):263. PubMed ID: 25769242
[No Abstract] [Full Text] [Related]
20. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.
Ware RE; Matthews JP; Hicks RJ; Porceddu S; Hogg A; Rischin D; Corry J; Peters LJ
Head Neck; 2004 Dec; 26(12):1008-17. PubMed ID: 15459925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
